SunTrust Downgrades NewLink Genetics (NLNK) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to SunTrust Downgrades NewLink Genetics (NLNK) to Neutral

NewLink Genetics Announces Results from Phase 3 IMPRESS Trial of Algenpantucel-L for Patients with Resected Pancreatic Cancer

May 9, 2016 4:01 PM EDT

Management to Host Conference Call

Tuesday, May 10th at 8:30 a.m. ET

AMES, Iowa, May 09, 2016 (GLOBE NEWSWIRE) --  NewLink Genetics Corporation (NASDAQ: NLNK) announced today results of its Phase 3 clinical trial for algenpantucel-L for patients with resected pancreatic cancer. 

The IMPRESS Phase 3 study of algenpantucel-L for patients with resected pancreatic cancer did... More